BPA for asceniv, bivigam

Active Awarded Last action

Contract number
36E79724A0025
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Last date to order 75% complete
IDV ceiling
$49,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center established a Blanket Purchase Agreement with Adma Biologics, Inc., on August 1, 2024, against the GSA Pharmaceuticals and Drugs schedule (FSS-61-IB), for the supply of ASCENIV and BIVIGAM, with a $49 million ceiling and a period of performance through July 31, 2027. This is a single-award BPA with no set-aside category. The agreement covers pharmaceutical and plasma-derived therapeutic products for federal healthcare operations, particularly supporting the Department of Veterans Affairs and its Integrated Service Networks. The source indicates the BPA is in its second option year of performance as of the award date.

Transactions

Action Obligated Date
Exercise an Option P00004 · Exercise option year 2 - BPA 36E79724A0025 $0
Supplemental Agreement for work within scope P00003 · 2026 public law pricing updates. $0
Exercise an Option P00002 · Exercise of option year 1 $0
Supplemental Agreement for work within scope P00001 · 2025 public law pricing updates $0
Original award $0

Quick answers

Who was awarded contract 36E79724A0025?

36E79724A0025 was awarded to Adma Biologics, Inc. by National Acquisition Center (Headquarters) on August 1, 2024.

How much is contract 36E79724A0025 worth?

36E79724A0025's own ceiling is $49,000,000.

Who can order from contract 36E79724A0025?

36E79724A0025 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79724A0025 under another contract?

Yes. 36E79724A0025 is a blanket purchase agreement under 36F79724D0080, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79724A0025 competed?

The extent of competition for 36E79724A0025 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV